University of California San Francisco
Give to UCSF
The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related, but often less deadly type, UCSF researchers have found in a new study.
Researchers from the UC San Francisco-affiliated Vascular Integrated Physiology and Experimental Therapeutics (VIPERx) Lab found that only a few days of being physically inactive may have detrimental effects on vascular function, in a pilot study recently published in the Journal of Surgical Research.
Researchers are recording brain activity in visually stunning ways that could lead to targeted therapies for Alzheimer’s, autism and other diseases.
UCSF neuroscientist Adam Gazzaley, MD, PhD, is hoping to paint a fuller picture of what is happening in the minds and bodies of those suffering from brain disease with his new lab, Neuroscape, which bridges the worlds of neuroscience and high-tech.
A UC San Francisco medical student thought of an idea that is now a bill, and could one day become law in California. Tom Gaither, a first year student at the UCSF School of Medicine, suggests putting the following warning label on sugary beverage containers that have 75 or more calories per 12 ounces: “STATE OF CALIFORNIA SAFETY WARNING: Drinking beverages with added sugar(s) contributes to obesity, diabetes and tooth decay.”
Scientists at the Gladstone Institutes and UCSF have made an important breakthrough: they have discovered a way to transform skin cells into mature, fully functioning liver cells that flourish.
Samsung Electronics Co., Ltd., and UC San Francisco have announced a partnership to accelerate validation and commercialization of promising new sensors, algorithms, and digital health technologies for preventive health solutions.
More than 70 percent of postdoctoral scholars and graduate students at UC San Francisco have a decreased desire to pursue an academic career in science, specifically due to the economic environment for science, according to an October 2013 survey run by UCSF postdoctoral scholars.
Genetic testing can help doctors choose the most effective and economical drugs to prevent blood clots in the half a million patients in the U.S. who receive coronary stents each year, according to a new study led by a UCSF researcher.
UCSF's four professional schools topped the nation in federal research funding in 2013, with the University ranking second overall in funds from the National Institutes of Health.
A look at National Institutes of Health funding to UCSF in 2013.
Scientists at the UCSF-affiliated Gladstone Institutes have found a way to efficiently edit the human genome one letter at a time, paving the way for therapies that cure disease.